Literature DB >> 173743

Metabolism and biological activity of parathyroid hormone in renal cortical membranes.

D Goltzman, A Peytremann, E N Callahan, G V Segre, J T Potts.   

Abstract

Recent studies from several laboratories have documented the presence of fragments of parathyroid hormone in blood or peripheral tissues or in both. Inasmuch as amino-terminal fragments are known to be biologically active, it has been suggested that fragments, rather than the intact polypeptide of 84 amino acids, might be the active molecular species in tissue fluids. Accordingly, the metabolism of native bovine parathyroid hormone, bPTH-(1-84), was studied in purified renal cortical membranes from several species and correlated with hormonal stimulation of adenylyl cyclase in these membranes in vitro. Analysis of whole incubation mixtures or membrane-bound hormone by gel electrophoresis and gel chromatography after incubation of [3H]bPTH-(1-84) or 125-I-labeled bPTH-(1-84) or unlabeled biologically active bPTH-(1-84) with purified canine renal cortical membranes revealed no evidence of proteolysis, and yet the uncleaved hormone readily stimulated adenylyl cyclase. Kinetic studies of hormone-stimulated adenylyl cyclase activity revealed no difference in rate of onset of activity between bPTH-(1-84) And the active synthetic amino-terminal tetratriacontapeptide bPTH-(1-34), and hence there was no evidence of precursor-product relationship between the native hormone and an active amino-terminal fragment. The results suggest, insofar as the activity detected in these membranes reflects the biological response of the hormone in vivo, that the native hormone is indeed biologically active at the receptor level directly without the requirement for cleavage into active fragments.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 173743      PMCID: PMC436619          DOI: 10.1172/JCI108272

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  Structure, synthesis, and mechanism of action of parathyroid hormone.

Authors:  G D Aurbach; H T Keutmann; H D Niall; G W Tregear; J L O'Riordan; R Marcus; S J Marx; J T Potts
Journal:  Recent Prog Horm Res       Date:  1972

2.  Solid-phase synthesis of the biologically active N-terminal 1 - 34 peptide of human parathyroid hormone.

Authors:  G W Tregear; J van Rietschoten; E Greene; H D Niall; H T Keutmann; J A Parsons; J L O'Riordan; J T Potts
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-04

3.  Proparathyroid hormone: identification of a biosynthetic precursor to parathyroid hormone.

Authors:  B Kemper; J F Habener; J T Potts; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

4.  Generation of a carboxyl-terminal fragment of bovine parathyroid hormone by canine renal plasma membranes.

Authors:  B Catherwood; F R Singer
Journal:  Biochem Biophys Res Commun       Date:  1974-03-25       Impact factor: 3.575

5.  Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity.

Authors:  G W Tregear; J Van Rietschoten; E Greene; H T Keutmann; H D Niall; B Reit; J A Parsons; J T Potts
Journal:  Endocrinology       Date:  1973-12       Impact factor: 4.736

6.  Isolation of human parathyroid hormone.

Authors:  H T Keutmann; P M Barling; G N Hendy; G V Segre; H D Niall; G D Aurbach; J T Potts; J L O'Riordan
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

7.  Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism.

Authors:  R C Benson; B L Riggs; B M Pickard; C D Arnaud
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

8.  Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments.

Authors:  J M Canterbury; G S Levey; E Reiss
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Heterogeneity of parathyroid hormone. Clinical and physiologic implications.

Authors:  R Silverman; R S Yalow
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.

Authors:  R S Goldsmith; J Furszyfer; W J Johnson; A E Fournier; G W Sizemore; C D Arnaud
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

View more
  4 in total

1.  Selective uptake of the synthetic amino terminal fragment of bovine parathyroid hormone by isolated perfused bone.

Authors:  K J Martin; J J Freitag; M B Conrades; K A Hruska; S Klahr; E Slatopolsky
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

2.  Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.

Authors:  D Goltzman; A S Tischler
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

3.  Isolation and analysis of human parathyrin in parathyroid tissue and plasma. Use of reversed-phase liquid chromatography.

Authors:  H P Bennett; S Solomon; D Goltzman
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

4.  Cytochemical bioassay of parathyroid hormone: characteristics of the assay and analysis of circulating hormonal forms.

Authors:  D Goltzman; B Henderson; N Loveridge
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.